Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients

BACKGROUND: This study evaluated the proportion of patients with atherosclerotic cardiovascular disease (ASCVD) and probable heterozygous familial hypercholesterolemia (HeFH) achieving ≥50% reduction in low-density lipoprotein cholesterol (LDL-C) or reaching the LDL-C ≤70 mg/dL threshold, after init...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ther Clin Risk Manag
Main Authors: Chen, Chi-Chang, Rane, Pallavi B, Hines, Dionne M, Patel, Jeetvan, Harrison, David J, Wade, Rolin L
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2018
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6296203/
https://ncbi.nlm.nih.gov/pubmed/30587999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S180783
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki